161 related articles for article (PubMed ID: 32845308)
1. Interaction between Lactobacillus reuteri and periodontopathogenic bacteria using in vitro and in vivo (G. mellonella) approaches.
Santos TA; Scorzoni L; Correia R; Junqueira JC; Anbinder AL
Pathog Dis; 2020 Nov; 78(8):. PubMed ID: 32845308
[TBL] [Abstract][Full Text] [Related]
2. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis.
Geraldo BMC; Batalha MN; Milhan NVM; Rossoni RD; Scorzoni L; Anbinder AL
J Periodontal Res; 2020 Apr; 55(2):215-220. PubMed ID: 31691977
[TBL] [Abstract][Full Text] [Related]
3. Withaferin A inhibits inflammatory responses induced by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages.
Noh EJ; Kang MJ; Jeong YJ; Lee JY; Park JH; Choi HJ; Oh SM; Lee KB; Kim DJ; Shin JA; Cho SD; Park JH
Mol Med Rep; 2016 Jul; 14(1):983-8. PubMed ID: 27220676
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria.
Kang MS; Oh JS; Lee HC; Lim HS; Lee SW; Yang KH; Choi NK; Kim SM
J Microbiol; 2011 Apr; 49(2):193-9. PubMed ID: 21538238
[TBL] [Abstract][Full Text] [Related]
5. Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages.
Park SR; Kim DJ; Han SH; Kang MJ; Lee JY; Jeong YJ; Lee SJ; Kim TH; Ahn SG; Yoon JH; Park JH
Infect Immun; 2014 May; 82(5):1914-20. PubMed ID: 24566622
[TBL] [Abstract][Full Text] [Related]
6. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study.
Teughels W; Durukan A; Ozcelik O; Pauwels M; Quirynen M; Haytac MC
J Clin Periodontol; 2013 Nov; 40(11):1025-35. PubMed ID: 24164569
[TBL] [Abstract][Full Text] [Related]
7. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
8. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
Galofré M; Palao D; Vicario M; Nart J; Violant D
J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
[TBL] [Abstract][Full Text] [Related]
9. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
[TBL] [Abstract][Full Text] [Related]
10. Heat-killed Lactobacillus acidophilus mediates Fusobacterium nucleatum induced pro-inflammatory responses in epithelial cells.
Ding Q; Sun X; Cao S; Zhao C; Wang Y; Wang X
FEMS Microbiol Lett; 2021 Apr; 368(5):. PubMed ID: 33693760
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes.
Gobbi E; De Francesco MA; Piccinelli G; Caruso A; Bardellini E; Majorana A
Eur Arch Paediatr Dent; 2020 Dec; 21(6):673-677. PubMed ID: 32034698
[TBL] [Abstract][Full Text] [Related]
12.
Santos TA; Scorzoni L; Santos AC; Junqueira JC; Anbinder AL
J Indian Soc Periodontol; 2020; 24(6):593-596. PubMed ID: 33424181
[TBL] [Abstract][Full Text] [Related]
13. The in Vitro Antimicrobial Efficacy of PDT against Periodontopathogenic Bacteria.
Haag PA; Steiger-Ronay V; Schmidlin PR
Int J Mol Sci; 2015 Nov; 16(11):27327-38. PubMed ID: 26580607
[TBL] [Abstract][Full Text] [Related]
14. Coaggregation and biofilm growth of Granulicatella spp. with Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans.
Karched M; Bhardwaj RG; Asikainen SE
BMC Microbiol; 2015 May; 15():114. PubMed ID: 26025449
[TBL] [Abstract][Full Text] [Related]
15. Increase of heat-shock protein and induction of gamma/delta T cells in peritoneal exudate of mice after injection of live Fusobacterium nucleatum.
Saito K; Katsuragi H; Mikami M; Kato C; Miyamaru M; Nagaso K
Immunology; 1997 Feb; 90(2):229-35. PubMed ID: 9135551
[TBL] [Abstract][Full Text] [Related]
16. Bacterial antagonism against periodontopathogens.
van Essche M; Loozen G; Godts C; Boon N; Pauwels M; Quirynen M; Teughels W
J Periodontol; 2013 Jun; 84(6):801-11. PubMed ID: 22897652
[TBL] [Abstract][Full Text] [Related]
17. Qualitative, quantitative and genotypic evaluation of Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum isolated from individuals with different periodontal clinical conditions.
Arenas Rodrigues VA; de Avila ED; Nakano V; Avila-Campos MJ
Anaerobe; 2018 Aug; 52():50-58. PubMed ID: 29857043
[TBL] [Abstract][Full Text] [Related]
18. In vitro assessment of the effect of probiotic lactobacillus reuteri on peri-implantitis microflora.
Mulla M; Mulla M; Hegde S; Koshy AV
BMC Oral Health; 2021 Aug; 21(1):408. PubMed ID: 34412595
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
20. Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells.
Li Y; Guo H; Wang X; Lu Y; Yang C; Yang P
Arch Oral Biol; 2015 Sep; 60(9):1387-93. PubMed ID: 26143497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
